MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/1756-185x.14333

Медицинская библиотека · International journal of rheumatic diseases · 2022

Rituximab on lung, skin, and joint involvement in patients with systemic sclerosis: A case series study and review of the literature.

Yarkan Tuğsal Handan, Zengin Berrin, Kenar Gökçe, Önen Fatoş, Birlik Merih

СтатьяОбзорПеревод в очереди

Аннотация

OBJECTIVES

To evaluate the effectiveness of rituximab (RTX) in systemic sclerosis (SSc) patients.

METHODS

Data were collected from patient charts before and after RTX administration for 1 year of follow-up time. An updated review of the literature was also done.

RESULTS

Of 8 patients enrolled (mean age: 62.4 years; mean disease duration: 16.7 years), 2 patients with pulmonary arterial hypertension (PAH) died after the first RTX cycle. The follow-up data of the remaining 6 patients were evaluated. There was a significant improvement in arthritis of Disease Activity Score of 28 joints - C-reactive protein and Clinical Disease Activity Index compared with baseline. The median change in modified Rodnan Skin Score (mRSS), forced vital capacity (FVC), and carbon monoxide diffusing capacity between baseline and 12 months were similar. Lung involvement was detected in 5/6 of survivor patients, FVC was improved in 2/5, worsened in 1/5, and remained stable in 2/5 at the end of 1 year. Among the 5 diffuse cutaneous SSc patients, none of the patients' mRSS deteriorated by more than 5 points, while one patient's mRSS improved by greater than 5 points.

CONCLUSION

This study suggests that RTX is effective for arthritis in patients with SSc. Also, the effectiveness of RTX in skin and lung involvement of SSc was predominantly toward stable disease or improvement. Despite the long disease duration, the presence of patients who showed improvement in skin and lung involvement after RTX treatment suggests the need to investigate predictors of RTX response.

Для цитирования: Yarkan Tuğsal Handan, Zengin Berrin, Kenar Gökçe, Önen Fatoş, Birlik Merih. Rituximab on lung, skin, and joint involvement in patients with systemic sclerosis: A case series study and review of the literature.. International journal of rheumatic diseases. 2022. DOI: 10.1111/1756-185x.14333.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.